Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0002090172-25-000001
Filing Date
2025-10-06
Accepted
2025-10-06 16:22:50
Documents
2
Period of Report
2025-10-01

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1537
2 POA taylorboyd.txt EX-24 4074
  Complete submission text file 0002090172-25-000001.txt   7184
Mailing Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087
Business Address 1500 LIBERTY RIDGE DRIVE SUITE 321 WAYNE PA 19087 410-522-8707
Avalo Therapeutics, Inc. (Issuer) CIK: 0001534120 (see all company filings)

EIN.: 450705648 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O AVALO THERAPEUTICS, INC. 1500 LIBERTY RIDGE DRIVE, SUITE 321 WAYNE PA 19087
Business Address
Boyd Taylor (Reporting) CIK: 0002090172 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-37590 | Film No.: 251377096